fetching data ...

POS1316 (2021)
VISUAL FUNCTION AND QUALITY OF LIFE: PRELIMINARY RESULTS FROM A PIVOTAL CROSS-SECTIONAL STUDY ON ONE HUNDRED PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS-ASSOCIATED AND IDIOPATHIC UVEITIS
G. B. Beretta1, F. Minoia1, L. Marelli2, C. Mapelli3, G. Leone3, T. Giani4, P. Nucci2,5, E. Miserocchi6, R. Cimaz7,8, on behalf of Pediatric Rheumatology Associated Group of the Milan Area
1Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Pediatric Rheumatology, Milan, Italy
2Ospedale San Giuseppe, IRCCS Multimedica, Ophthalmology, Milan, Italy
3Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Ophthalmology, Milan, Italy
4Università degli Studi di Siena, Pediatric Rheumatology, Siena, Italy
5Università degli Studi di Milano, Ophthalmology, Milan, Italy
6IRCCS Ospedale San Raffaele, Ophthalmology, Milan, Italy
7ASST Gaetano Pini-CTO, Milan, Italy, Pediatric Rheumatology, Milan, Italy
8Università degli Studi di Milano, Pediatric Rheumatology, Milan, Italy

Background: Juvenile idiopathic arthritis (JIA) is the main cause of chronic uveitis in childhood and JIA associated uveitis (JIA-U) is the most common extraarticular complication of JIA. Despite continuous improvement in its management, pediatric uveitis still represents a serious condition with potential sight-threatening complications and a significant impact on quality of life (QoL).


Objectives: To evaluate visual function (VF) and QoL in children with JIA-U and idiopathic uveitis


Methods: A cross-sectional study was conducted in two tertiary Pediatric Rheumatology Centres, enrolling all patients seen with JIA-U, JIA without uveitis and idiopathic uveitis. VF was assessed by a translated form of the available EYE-Q, adapted for cross-cultural feasibility into a 10-question tool, while QoL was evaluated by the Italian version of the Pediatric Rheumatology Quality of Life scale part of the Juvenile Arthritis Multidimensional Report (JAMAR), shortened for feasibility to a 8-question tool. JAMAR section on treatment compliance and school attendance was also included. Parents, and patients when appropriate, were asked to complete each patient/parent-reporting outcome measure, answering on a 4-point Likert scale, with a total score ranging from 0 to 72 (worst condition). Medical charts were reviewed regarding JIA and uveitis features and outcome. Quantitative and qualitative variables were compared by means of Mann-Whitney U test or chi-square/Fisher exact test, as appropriate; correlations among quantitative non-parametric variables were evaluated by Spearman’s test.


Results: We herein describe results from the first 100 patients enrolled (76% female), with a median age at study time of 12.8 (9.0-17.6) years. Forty-nine had JIA-U, 37 JIA without uveitis and 14 idiopathic uveitis. Uveitis was active in 14/63 patients (22.2%), with a median of uveitis duration of 9.0 years (3.6-14.8). Almost all children with uveitis were on systemic treatment (58/63, 92%) at the time of interview; 54.0% of patients presented an ocular damage, with 8.0% having a best corrected visual acuity (BCVA) < 4/10. Total score, VF and QoL scores resulted significantly higher in JIA-U patients compared to JIA without uveitis, while no differences were noticed among children with uveitis with or without JIA ( Table 1 ). School absence was reported more frequently in JIA-U compared to JIA only (32.7% vs 10.8%, p 0.0211). VF was significantly worse in patients with ocular damage and BCVA < 4/10 (p 0.0351 and 0.0123, respectively). In patients with uveitis, VF and QoL showed a significant correlation (r 0.50, p <0.0001) especially in patients with idiopathic uveitis (r 0.74, p <0.0001).


Conclusion: Visual function is a crucial component of QoL in children with uveitis and it correlates with ocular damage. Since eye involvement significantly affect QoL in patients with JIA, a specific tool widely validated and cross-cultural adapted is highly demanded in the clinical care of JIA-U patients.


REFERENCES:

[1]Angeles-Han ST et al. The importance of visual function in the quality of life of children with uveitis. J AAPOS, 2010. Filocamo et al. A New Approach to Clinical Care of Juvenile Idiopathic Arthritis: The Juvenile Arthritis Multidimensional Assessment Report. J Rheumatol, 2011.

JIA-U n = 49 Idiopathic uveitis n = 14 JIA n = 37 p-value* p-value #
Total score 5.0 (3.0-11.0) 4.5(2-9.8) 2.0(0-4.0) 0.5739 <0.0001
VF score 2.0 (0-3.0) 1.0(0-3.0) 0(0-0) 0.9098 <0.0001
QoL score 3.0(2.0-6.0) 3.5(2.0-4.8) 2.0(0-4.0) 0.5611 0.0005

Numbers are medians (IQR). * JIA-U vs idiopathic uveitis; # JIA-U vs JIA


Disclosure of Interests: None declared


Citation: Ann Rheum Dis, volume 80, supplement 1, year 2021, page 940
Session: Paediatric rheumatology (POSTERS only)